Latest filing published 13 Mar 2019 for Immucell CORP, €18k.
Insider track record
No signal scores available.
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +12.7%Entry US$6.95 · Close at T+365 US$7.83
- +58.6%Entry US$4.73 · Close at T+365 US$7.50
- +25.6%Entry US$5.35 · Close at T+365 US$6.72
- +67.9%Entry US$4.70 · Close at T+365 US$7.89
- +70.5%Entry US$4.65 · Close at T+365 US$7.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paul R. Wainman: trading record in brief
Paul R. Wainman appears in our data through filings on Immucell Corp shares, published by SEC (Form 4). Between 11 June 2014 and 11 March 2019, the trades on record add up to 9 filings.
On the market, this insider has only ever bought: 8 purchases, €9,393 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant.
In size, the median ticket on the buying side is €790. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 71% of cases; the median change was +6.9%. These figures describe past trades and do not predict future prices.
On 13 March 2019 came the latest disclosure, a share grant for €18k in Immucell Corp. The most recent open-market purchase was published on 16 September 2015, 4,072 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul R. Wainman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,269 shares@ US$4.80100.0% of flowCommon Stock, par value $0.10 per shareSEC:0001213900-19-004013:0
- 175 shares@ US$6.80Common Stock, par value $0.10 per shareSEC:0001547522-15-000167:0Canonical exit: 13 Dec 2015 (T+90)
- 200 shares@ US$4.80Common Stock, par value $0.10 per shareSEC:0001547522-14-000100:0Canonical exit: 11 Feb 2015 (T+90)
- 200 shares@ US$4.80Common Stock, par value $0.10 per shareSEC:0001547522-14-000100:1Canonical exit: 12 Feb 2015 (T+90)
- 225 shares@ US$4.50Common Stock, par value $0.10 per shareSEC:0001547522-14-000077:0Canonical exit: 15 Dec 2014 (T+90)
- 200 shares@ US$4.50Common Stock, $0.10 par valueSEC:0001547522-14-000067:0Canonical exit: 17 Nov 2014 (T+90)
- 250 shares@ US$4.35Common Stock, $0.10 par valueSEC:0001547522-14-000040:0Canonical exit: 24 Sept 2014 (T+90)
- 750 shares@ US$4.10Common Stock, $0.01 par valueSEC:0001547522-14-000029:0Canonical exit: 9 Sept 2014 (T+90)
8 of 8 declarations